
David C Dale MD
Professor, Medicine, University of Washington School of Medicine
Join to View Full Profile
1959 Ne Pacific StSeattle, WA 98195
Phone+1 206-543-7215
Dr. Dale is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of WashingtonResidency, Internal Medicine, 1971 - 1972
- Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1967 - 1968
- Massachusetts General HospitalInternship, Transitional Year, 1966 - 1967
- Harvard Medical SchoolClass of 1966
Certifications & Licensure
- WA State Medical License 1971 - 2026
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Clinicopathologic features and the spectrum of myelokathexis in WHIM syndrome.Jingwei Li, Marine Delecourt-Billet, Odile Fenneteau, Jadee L Neff, Lilian Roland
Laboratory Investigation; a Journal of Technical Methods and Pathology. 2025-04-14 - European guidelines on treatment and supportive measures in chronic neutropenias: A consensus between the European Hematology Association and the EuNet-INNOCHRON COST ...Francesca Fioredda, Michail Spanoudakis, Julia Skokowa, Hannah Tamary, Piero Farruggia
Hemasphere. 2025-04-01 - 19 citationsA phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome.Raffaele Badolato, Laia Alsina, Antoine Azar, Yves Bertrand, Audrey A Bolyard
Blood. 2024-07-04
Abstracts/Posters
- CRISPR/Cas9 Mediated ELANE Knock-out Restores Survival and Granulocytic Differentiation of HL60 Cells Expressing Mutant Neutrophil Elastase: Is Neutrophil Elastase a D...David C. Dale, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Heterozygous Mutations of Clpb As a Newly Identified and Frequent Cause of Severe Congenital NeutropeniaDavid C. Dale, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Grant Support
- Gene Editing vs Neutrophil Elastase Inhibitors for Treatment of ELANE Associated NeutropeniaUNIVERSITY OF WASHINGTON2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: